Kinesiological Taping in Individuals with Meniscus Injury

October 9, 2024 updated by: Kübra Okuyucu, Amasya University

Acute Effect of Kinesiological Taping on Pain, Quality of Life and Musculoskeletal System Parameters in Individuals with Meniscus Injury: a Randomized, Placebo-Controlled Study

This study aims to explore how kinesiology taping affects people with mild to moderate meniscus injuries (grades I/II), focusing on pain, movement fears, muscle strength, balance, joint movement, and quality of life.

Two groups will be involved: one will receive kinesiology taping on the thigh muscle with some tension, while the other will receive a placebo tape with no tension. Researchers will measure various factors, including pain and muscle strength, both before and 48-72 hours after taping.

Study Overview

Status

Completed

Conditions

Detailed Description

This study aims to understand the short-term (acute) effects of kinesiology taping on people with mild to moderate meniscus injuries (grade I/II). These injuries, affecting the cartilage in the knee, can cause pain, reduced mobility, and fear of movement. Kinesiology taping, a popular therapy, involves applying elastic tape to support muscles and joints. This research looked at whether taping could improve pain, muscle strength, movement, balance, and quality of life in patients with these knee injuries.

Study Design The study will use a randomized, placebo-controlled, and double-blinded design, meaning that patients were randomly assigned to two groups, and neither the patients nor the researchers knew which group each person was in during the treatment.

Experimental Group: will receive kinesiology taping on the quadriceps muscle (the large muscle at the front of the thigh) using a 'Y-shaped' technique with moderate tension (25-50% stretch).

Control Group: will receive a placebo tape applied without tension and placed in a different direction.

Measurements

To evaluate the effects of taping, several aspects will be measured both before the tape was applied and 48-72 hours later:

Pain levels Fear of movement (kinesiophobia) Muscle strength (ability to extend the knee) Proprioception (awareness of limb position and force applied) Joint range of motion (how much the knee can bend and straighten) Joint position sense (accuracy in detecting knee position with eyes closed) Quality of life, using a questionnaire (SF-36) that assesses various aspects like physical function and energy levels.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merkez
      • Amasya, Merkez, Turkey, 05100
        • Amasya University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients diagnosed with meniscus grade I/II,
  • Who agreed to participate in the study
  • Signed the voluntary consent form

Exclusion Criteria:

  • Pregnant individuals
  • Individuals with additional knee injuries (e.g., ligament tears) or chronic conditions affecting the knee (e.g., arthritis).
  • Patients with grade III meniscus tears or more severe injuries.
  • Who had knee surgery in the last 6 months.
  • Patients with skin conditions or allergies to adhesive materials or kinesiology tape.
  • Individuals with neurological conditions such as multiple sclerosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: The experimental group
This group was applied 'Y shaped' kinesiology taping on quadriceps femoris muscle, based on facilitation technique with 25-50% stretching.
'Y shaped' kinesiology taping was applied on quadriceps femoris muscle, based on facilitation technique with 25-50% stretching.
Placebo Comparator: The placebo group
This group was applied a tape without tension, perpendicular to the quadriceps femoris muscle
A tape without tension was applied perpendicular on the quadriceps femoris muscle.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain
Time Frame: Baseline and 48 hours after the application
Pain assessment was made with Visual Analogue Scale (VAS). The patient was asked to mark where his or her pain was on the scale by writing "0: No pain, 10: Unbearable pain" at the two ends of the 10-centimeter scale.
Baseline and 48 hours after the application
Knee extension muscle strength
Time Frame: Baseline and 48 hours after the application
A hand dynamometer (MicroFet 2 HHD) was used to measure the patients' knee extension muscle strength. Measurements were recorded in kilograms. For measurement, the patient was positioned without support, with his legs hanging off the bed from the knees, knees flexed at 90°, feet free and arms crossed over the shoulders. During the measurement, the thigh to be measured was stabilized with one hand after the patients completed maximum knee extension.
Baseline and 48 hours after the application

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fear of movement
Time Frame: Baseline and 48 hours after the application
It was evaluated with the Tampa Kinesiophobia Scale (TKÖ). This scale, developed to measure fear of movement/re-injury, consists of 17 questions. The scale includes injury/re-injury and fear-avoidance parameters in work-related activities.
Baseline and 48 hours after the application
Proprioceptive force sense
Time Frame: Baseline and 48 hours after the application
It was evaluated with a pressurized biofeedback device. While the patients were lying on the treatment bed in a supine position, the biofeedback device was placed under the knee and its pressure was adjusted to 20 mmHg. Patients were asked to make maximum isometric contraction of the quadriceps femoris muscle and maintain it for 5 seconds. The highest value read from the device during the patients' contractions was recorded.
Baseline and 48 hours after the application
Joint range of motion
Time Frame: Baseline and 48 hours after the application
Knee flexion range of motion measurements were made using a goniometer while the patient was lying in the prone position.
Baseline and 48 hours after the application
Joint position sense
Time Frame: Baseline and 48 hours after the application
Baseline Digital Inclinometer was used for this. Knee extension movement was performed for the right and left extremities in eyes open and eyes closed positions. The reposition angle method was used to measure joint position sense. According to this method; The patient's extremity was moved to the required position by the physiotherapist. The patient was asked to remember this position by waiting 5 seconds in this position. The patient was then asked to bring his extremity back to that position.
Baseline and 48 hours after the application
Quality of life
Time Frame: Baseline and 48 hours after the application
It was evaluated using the SF-36 scale. The scale consists of a total of 36 questions in eight subsections. These sections are: physical function, body pain, limitation due to physical problems, limitation due to emotional problems, cognitive well-being, social competence, energy, general health. In the scale, each section is evaluated separately, and each question is scored between 0 and 100. The increase in score is interpreted as an improvement in health status.
Baseline and 48 hours after the application

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2022

Primary Completion (Actual)

August 1, 2023

Study Completion (Actual)

August 1, 2024

Study Registration Dates

First Submitted

October 3, 2024

First Submitted That Met QC Criteria

October 9, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

October 15, 2024

Last Update Submitted That Met QC Criteria

October 9, 2024

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 81180

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Meniscus Tears

Clinical Trials on Kinesiology taping

Subscribe